|
| Biotinylated Human IL-18 Protein (Primary Amine Labeling) (LTP10223) |
|
| LTP10223 |
|
| 100ug |
|
|
$789 In stock |
| Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-? production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-? production in response to IL-18 stimulation. |
| Recombinant Biotinylated Human IL-18 Protein (Primary Amine Labeling) is expressed from E.coli without tag. It contains Tyr37-Asp193. |
|
| IL-18 |
|
| Human |
|
| Q14116 |
|
| Tyr37-Asp193 |
|
| The protein has a predicted MW of 18.2 kDa same as Tris-Bis PAGE result. |
|
| Immobilized Human IL-18BP, hFc Tag at 5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human IL-18, No Tag with the EC50 of 26.0ng/ml determined by ELISA. See testing image for detail. |
|
| No Tag |
|
| E.coli |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
